1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014

Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014" provides data on the Familial Mediterranean Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Familial Mediterranean Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Familial Mediterranean Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Familial Mediterranean Fever 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Familial Mediterranean Fever to Immunology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Familial Mediterranean Fever to Immunology Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Familial Mediterranean Fever 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Familial Mediterranean Fever Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Sun Pharmaceutical Industries Limited 27
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 27
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Bellus Health Inc. 29
Clinical Trial Overview of Bellus Health Inc. 29
Clinical Trial Overview of Top Institutes / Government 30
The Sheba Medical Center 30
Clinical Trial Overview of The Sheba Medical Center 30
National Institute of Arthritis and Musculoskeletal and Skin Diseases 31
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 31
The Cleveland Clinic 32
Clinical Trial Overview of The Cleveland Clinic 32
Rambam Health Care Campus 33
Clinical Trial Overview of Rambam Health Care Campus 33
Five Key Clinical Profiles 34
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables

Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Region, 2014* 6
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Familial Mediterranean Fever Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 9
Familial Mediterranean Fever Therapeutics Clinical Trials, North America, Top Countries, 2014* 10
Familial Mediterranean Fever Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 11
Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, G7 Countries (%), 2014* 12
Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, E7 Countries (%), 2014* 15
Familial Mediterranean Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 16
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Familial Mediterranean Fever Therapeutics, Global, Withdrawn Clinical Trials, 2014* 21
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Familial Mediterranean Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2014* 27
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 28
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellus Health Inc., 2014* 29
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 30
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 31
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 32
Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014* 33

List of Figures

Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Familial Mediterranean Fever Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 9
Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, G7 Countries (%), 2014* 12
Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, E7 Countries (%), 2014* 15
Familial Mediterranean Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 16
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Familial Mediterranean Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.